Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Elan turns 1Q profit as Tysabri sales rise
Yahoo/AP
Wednesday, April 20, 2011 - 12:04pm
tags:
Elan, earnings
FDA approves Genentech vasculitis treatment
Bizjournals.com
Wednesday, April 20, 2011 - 12:04pm
tags:
FDA, Genentech, vasculitis, Rituxan
Lilly Will Pay Investors For Patience
Investopedia
Wednesday, April 20, 2011 - 12:02pm
tags:
invesors, Eli Lilly
Mylan now selling generic version of Novartis' herpes drug Famvir
Yahoo/AP
Wednesday, April 20, 2011 - 12:01pm
tags:
Mylan, generics, Famvir, Novartis, herpes zoster
Sangamo Biosciences's Game Changing Technology
Seeking Alpha
Wednesday, April 20, 2011 - 9:57am
tags:
Sangamo BioSciences, ZFP technology
U.S. Backs Roche Cervical Cancer Test
WSJ Online
Wednesday, April 20, 2011 - 9:56am
tags:
Roche, cervical cancer
Is BioSante Giving Away the Store?
Motley Fool
Wednesday, April 20, 2011 - 9:55am
tags:
BioSante, Aduro BioTech, pancreatic cancer, prostate cancer
Dendreon's Price Run May Be in Anticipation of Stronger Earnings
Seeking Alpha
Wednesday, April 20, 2011 - 9:54am
tags:
Dendreon, Provenge, prostate cancer
SciClone buys U.S.-backed Chinese drug company
Bizjournals.com
Wednesday, April 20, 2011 - 9:52am
tags:
China, SciClone, M&A, NovaMed
FDA Heightens Painkiller Oversight
WSJ Online
Wednesday, April 20, 2011 - 9:51am
tags:
painkillers, opiods, FDA
Abbott 1Q profit falls 14 percent on charges
Yahoo/AP
Wednesday, April 20, 2011 - 9:50am
tags:
earnings, Abbott Laboratories
What Drug Did Doctors Prescribe Most Last Year?
WSJ Online
Tuesday, April 19, 2011 - 10:18pm
tags:
physicians, prescription data, Vicodin, generics
Covidien, Zalicus drugs hit by new federal 'opioid strategy'
Bizjournals.com
Tuesday, April 19, 2011 - 10:16pm
tags:
Covidien, Zalicus, opiods, Exalgo, JNJ
The Fall of Lipitor
Minyanville
Tuesday, April 19, 2011 - 10:15pm
tags:
Pfizer, Lipitor, generics, patents
Biogen’s 'Avonex Pen' wins tentative EU nod
Bizjournals.com
Tuesday, April 19, 2011 - 11:18am
tags:
Biogen Idec, Avonex, MS, multiple sclerosis, Europe, Avonex pen
ViroPharma loses challenge to generic drug rule
Yahoo/AP
Tuesday, April 19, 2011 - 11:14am
tags:
ViroPharma, generics, Vancocin
Regeneron eye drug gets priority FDA review
Yahoo/AP
Tuesday, April 19, 2011 - 11:12am
tags:
Regeneron, FDA, VEGF Trap-Eye
Earnings Preview: Amgen to report 1Q results
Yahoo/AP
Tuesday, April 19, 2011 - 11:11am
tags:
earnings, Amgen
Earnings Preview: Gilead Sciences
Yahoo/Zacks.com
Tuesday, April 19, 2011 - 11:10am
tags:
Gilead Sciences, earnings
Novavax Has Over 400% Upside Potential
Seeking Alpha
Tuesday, April 19, 2011 - 11:09am
tags:
Novavax, vaccines

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.